CAS 1627856-64-7

GSK3179106

CAS : 1627856-64-7

Formule : C₂₂H₂₁F₄N₃O₄

Degré de pureté : 99%

Masse moléculaire : 467.4135

Ref: IN-DA01EO4W

GSK3179106

CAS : 1627856-64-7

GSK3179106

Degré de pureté : ≥98%

Masse moléculaire : 467.41g/mol

Ref: 54-BUP09107

2-(4-(4-Ethoxy-6-Oxo-1,6-Dihydropyridin-3-Yl)-2-Fluorophenyl)-N-(5-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)Isoxazol-3-Yl)Acetamide

CAS : 1627856-64-7

2-(4-(4-Ethoxy-6-Oxo-1,6-Dihydropyridin-3-Yl)-2-Fluorophenyl)-N-(5-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)Isoxazol-3-Yl)Acetamide

Degré de pureté : 99%

Masse moléculaire : 467.41g/mol

Ref: 54-PC108424

GSK3179106

CAS : 1627856-64-7

GSK3179106 is RET kinase inhibitor with an IC50 of 0.4 nM

Formule : C₂₂H₂₁F₄N₃O₄

Degré de pureté : 99.8% - 99.90%

Couleur et forme : Solid

Masse moléculaire : 467.41

Ref: TM-T5491

GSK3179106

CAS : 1627856-64-7

GSK3179106 is a potent and selective inhibitor of the enzyme GSK3. It has been shown to have effects on acetylcholine levels, which may be due to its ability to modulate choline uptake. GSK3179106 has also been shown to inhibit cancerous growth by blocking the activation of the EGFR mutant in ganglion cells. This drug binds with high affinity to the receptor for acetylcholine at the neuromuscular junction and blocks neuronal function.

Formule : C₂₂H₂₁F₄N₃O₄

Degré de pureté : Min. 95%

Masse moléculaire : 467.41 g/mol

Ref: 3D-CQC85664